Current Concepts in Surgical Pathology

Overview

Elevate Your Surgical Pathology CME

Current Concepts in Surgical Pathology, an online CME course, presents a broad overview of key areas of surgical pathology and intends to update both academic and community pathologists with new advances in the field.

Expert faculty deliver case-based lectures on topics like lymph node diagnosis, gestational trophoblast disease, DLBCL, inflammatory bowel disease, and more. This surgical pathology continuing medical education program will help you to:

• Apply new criteria for pathologic diagnoses in multiple areas of surgical pathology
• Recognize unusual entities
• Assess the decision making process used to arrive at specific diagnoses
• Utilize contemporary tumor classification systems
• Apply IHC and/or molecular studies judiciously to establish or confirm diagnoses

Topics / Speakers

Deceptive Patterns and Mimics of Invasive Breast Cancer
Melinda J. Lerwill, MD

Approach to Lymph Node Diagnosis
Judith A. Ferry, MD

Non-Invasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features and Thyroid Tumors with a Follicular Pattern
William C. Faquin, MD, PhD

Problems in Ovarian Tumor Interpretation
Mistakes that May Cause Harm to the Patient or Embarrass the Pathologist: Part I
Robert H. Young, MD

Diffuse Large B-Cell Lymphoma: Problems and Peculiarities in Diagnosis
Aliyah R. Sohani, MD

Placental Pathologies that Necessitate Intervention
Drucilla J. Roberts, MD

lnflammatory Bowel Disease: Challenges and Controversies
Joseph Misdraji, MD

Problems in Ovarian Tumor Interpretation: Part II
Robert H. Young, MD

Myelodysplasia and Myeloproliferative Neoplasms
Robert P. Hasserjian, MD

Ductal Carcinoma In-Situ: Diagnostic Evaluation and Problematic Patterns
Melinda J. Lerwill, MD

Neuroendocrine Tumors of the Gastrointestinal and Pancreaticobiliary Tracts
Vikram Deshpande, MD

Gestational Trophoblast Disease
Drucilla J. Roberts, MD

Pancreaticobiliary Neoplasms and their Mimics
Vikram Deshpande, MD

Interstitial Lung Disease
Lida P. Hariri, MD, PhD

Classification and Genetics of Familial Thyroid Carcinoma
Vania Nosé, MD, PhD

Polyps and Other Precursors Lesions in the Colon
Lawrence R. Zukerberg, MD

Mesenchymal Neoplasms of the Uterus
Esther Oliva, MD

Update on Gastritis
Lawrence R. Zukerberg, MD

Approach to Ancillary Testing in Epithelioid Soft Tissue Tumors
Ivan A. Chebib, MD

Lung Carcinoma: Selected Issues in Histologic Classification
Mari Mino-Kenudson, MD

Practical Aspects of Meningioma Diagnosis
David N. Louis, MD

Neuropathology Frozen Section Interpretation: Problems and Pitfalls
Maria Martinez-Lage, MD

Hodgkin's Lymphoma and Its Differential Diagnosis
Judith A. Ferry, MD

The Application of Immunohistochemistry in the Differential Diagnosis of Ovarian Tumors
Esther Oliva, MD

Common Problems in Liver Biopsy Interpretation
Joseph Misdraji, MD

Salivary Gland Pathology
Peter M. Sadow, MD, PhD

Mucinous Lesions of the Breast
Veerle I.J. Bossuyt, MD

Vasculitis
James R. Stone, MD

Follicular Lymphoma
Abner Louissaint, Jr., MD, PhD

Renal Tumors: An Update
Kristine Cornejo, MD

Clinically Important Diagnoses in Sinonasal Pathology
William C. Faquin, MD, PhD

Adrenal Pathology
Peter M. Sadow, MD, PhD

Grading and Staging of Urologic Cancers: An Interactive Exercise
Chin-Lee Wu, MD, PhD

Pleomorphic Lobular and Variant Forms of Mammary Carcinoma In Situ
Travis L. Rice-Stitt, MD

Evaluation of Treatment-Related Changes in Breast Cancer
Elena F. Brachtel, MD

Instructive Cases
William C. Faquin, MD, PhD; Judith A. Ferry, MD; and Melinda J. Lerwill, MD

Faculty

Accreditation

The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Harvard Medical School designates this enduring material for a maximum of 29 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Pathology (ABP)

This activity is approved for 29 credits of Lifelong Learning (Part II) and Self-Assessment Module (SAM) eligible credits towards the American Board of Pathology's Maintenance of Certification Program.

Canadian Accreditation

The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.

European Accreditation

Through an agreement between the American Medical Association and the European Union of Medical Specialists, physicians may convert AMA PRA Category 1 Credits ™ to an equivalent number of European CME Credits® (ECMEC®s). Information on the process of converting AMA PRA Category 1 Credits ™ to ECMEC®s can be found at: www.eaccme.eu.

Date of Original Release: January 15, 2020
Termination Date: January 15, 2023 (Please note that AMA PRA Category 1 Credits ™ will no longer be issued for the activity after this date)
Estimated Time to Complete the Activity: 29 hours

CME credit is awarded upon successful completion of a course evaluation and post-test.

IOM Competencies

The course is designed to meet the following Institute of Medicine (IOM) Competencies:

• Provide Patient-Centered Care
• Employ Evidence-Based Practice

ACGME Competencies

This course is designed to meet the following American Board of Medical Specialties (ABMS)/Accreditation Council for Graduate Medical Educational (ACGME) competencies:

• Medical Knowledge
• Practice-Based Learning and Improvement
• System-Based Practices

Learning Objectives

After viewing this program, participants will be better able to:

• Apply new criteria for pathologic diagnoses in multiple areas of surgical pathology
• Recognize unusual entities
• Evaluate the decision making process used to arrive at specific diagnoses
• Utilize contemporary tumor classification systems
• Apply immunohistochemistry and/or molecular studies judiciously to establish or confirm diagnoses

Target Audience

This course is targeted to physicians who specialize in pathology.

Disclosure Policy

Harvard Medical School (HMS) adheres to all ACCME Accreditation Criteria and Policies. It is HMS's policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

Disclosure information for all individuals in control of the content of the activity is located on the disclosure statement in the PDF and printed syllabus.

Disclaimer

CME activities accredited by Harvard Medical School are offered solely for educational purposes and do not constitute any form of certification of competency. Practitioners should always consult additional sources of information and exercise their best professional judgment before making clinical decisions of any kind.

Quick Facts

Provider: Harvard Medical School and Massachusetts General Hospital

Course Director:
William C. Faquin, MD, PhD
Massachusetts General Hospital

Harvard Medical School

Judith A. Ferry, MD
Massachusetts General Hospital

Harvard Medical School

Melinda J. Lerwill, MD
Massachusetts General Hospital

Harvard Medical School

Robert H. Young, MD
Massachusetts General Hospital

Harvard Medical School

Credits: Earn a maximum of 29 AMA PRA Category 1 Credits™